Gilbert DN - Search Results

1

Nebulized Antibiotics for Multidrug-Resistant Ventilator-Associated Pseudomonas aeruginosa Pneumonia.

Gilbert DN. Gilbert DN. Crit Care Med. 2019 Jun;47(6):880-881. doi: 10.1097/CCM.0000000000003751. Crit Care Med. 2019. PMID: 31095023 No abstract available.

2

Scenario 2: A patient with ventilator-associated bacterial pneumonia--introduction to clinical trial design issues.

Gilbert DN. Gilbert DN. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S100-2. doi: 10.1086/653056. Clin Infect Dis. 2010. PMID: 20597656

3

Influence of an infectious diseases specialist on ICU multidisciplinary rounds.

Gilbert DN. Gilbert DN. Crit Care Res Pract. 2014;2014:307817. doi: 10.1155/2014/307817. Epub 2014 Apr 17. Crit Care Res Pract. 2014. PMID: 24860663 Free PMC article.

4

Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future?

Nielsen TB, Brass EP, Gilbert DN, Bartlett JG, Spellberg B. Nielsen TB, et al. Among authors: gilbert dn. N Engl J Med. 2019 Aug 8;381(6):503-505. doi: 10.1056/NEJMp1905589. Epub 2019 Jun 19. N Engl J Med. 2019. PMID: 31216396 Free PMC article. No abstract available.

5

The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett.

Spellberg B, Gilbert DN. Spellberg B, et al. Among authors: gilbert dn. Clin Infect Dis. 2014 Sep 15;59 Suppl 2(Suppl 2):S71-5. doi: 10.1093/cid/ciu392. Clin Infect Dis. 2014. PMID: 25151481 Free PMC article.

6

The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia.

Gelfer G, Leggett J, Myers J, Wang L, Gilbert DN. Gelfer G, et al. Among authors: gilbert dn. Diagn Microbiol Infect Dis. 2015 Dec;83(4):400-6. doi: 10.1016/j.diagmicrobio.2015.08.001. Epub 2015 Aug 5. Diagn Microbiol Infect Dis. 2015. PMID: 26341706 Free PMC article.

7

Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.

Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE. Gilbert DN, et al. Antimicrob Agents Chemother. 2001 Mar;45(3):883-92. doi: 10.1128/AAC.45.3.883-892.2001. Antimicrob Agents Chemother. 2001. PMID: 11181375 Free PMC article.

8

The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia.

Gilbert D, Gelfer G, Wang L, Myers J, Bajema K, Johnston M, Leggett J. Gilbert D, et al. Diagn Microbiol Infect Dis. 2016 Sep;86(1):102-7. doi: 10.1016/j.diagmicrobio.2016.06.008. Epub 2016 Jun 15. Diagn Microbiol Infect Dis. 2016. PMID: 27377675 Free PMC article.

9

Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians.

Banniettis N, Beekmann SE, Polgreen PM, Kaushik S, Kohlhoff S, Gilbert D, Bennett JE, Hammerschlag MR. Banniettis N, et al. Open Forum Infect Dis. 2018 May 19;5(5):ofy093. doi: 10.1093/ofid/ofy093. eCollection 2018 May. Open Forum Infect Dis. 2018. PMID: 29876367 Free PMC article.

10

Clinical end points of therapy for patients with mild community-acquired pneumonia.

Gilbert DN. Gilbert DN. Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S140-4. doi: 10.1086/591395. Clin Infect Dis. 2008. PMID: 18986280 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results